TY - JOUR
T1 - Expression and action of cyclic GMP-dependent protein kinase Iα in inflammatory hyperalgesia in rat spinal cord
AU - Tao, Y. X.
AU - Hassan, A.
AU - Haddad, E.
AU - Johns, R. A.
N1 - Funding Information:
This work is supported by NIH Grants RO1 GM49111 and RO1 HL39706. The authors thank Fengying Wang for her assistance in Fos immunohistochemistry, and Nan Zhou and Ninghong Da for consultation on western blot analysis.
PY - 1999/12
Y1 - 1999/12
N2 - Several lines of evidence have shown a role for the nitric oxide/cyclic guanosine monophosphate signaling pathway in the development of spinal hyperalgesia. However, the roles of effectors for cyclic guanosine monophosphate are not fully understood in the processing of pain in the spinal cord. The present study showed that cyclic guanosine monophosphate-dependent protein kinase Iα but not Iβ was localized in the neuronal bodies and processes, and was distributed primarily in the superficial laminae of the spinal cord. Intrathecal administration of a selective inhibitor of cyclic guanosine monophosphate-dependent protein kinase Iα, Rp-8-[(4-chlorophenyl)thio]-cGMPS triethylamine, produced a significant antinociception demonstrated by the decrease in the number of flinches and shakes in the formalin test. This was accompanied by a marked reduction in formalin-induced c-fos expression in the spinal dorsal horn. Moreover, cyclic guanosine monophosphate-dependent protein kinase Iα protein expression was dramatically increased in the lumbar spinal cord 96h after injection of formalin into a hindpaw, which occurred mainly in the superficial laminae on the ipsilateral side of a formalin-injected hindpaw. This up-regulation of cyclic guanosine monophosphate-dependent protein kinase Iα expression was completely blocked not only by a neuronal nitric oxide synthase inhibitor, 7-nitroindazole, and a soluble guanylate cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, but also by an N-methyl-D-aspartate receptor antagonist, dizocilpine maleate (MK-801).The present results indicate that noxious stimulation not only initially activates but also later up-regulates cyclic guanosine monophosphate-dependent protein kinase Iα expression in the superficial laminae via an N-methyl-D-aspartate-nitric oxide-cyclic guanosine monophosphate signaling pathway, suggesting that cyclic guanosine monophosphate-dependent protein kinase Iα may play an important role in the central mechanism of formalin-induced inflammatory hyperalgesia in the spinal cord. Copyright (C) 1999 IBRO.
AB - Several lines of evidence have shown a role for the nitric oxide/cyclic guanosine monophosphate signaling pathway in the development of spinal hyperalgesia. However, the roles of effectors for cyclic guanosine monophosphate are not fully understood in the processing of pain in the spinal cord. The present study showed that cyclic guanosine monophosphate-dependent protein kinase Iα but not Iβ was localized in the neuronal bodies and processes, and was distributed primarily in the superficial laminae of the spinal cord. Intrathecal administration of a selective inhibitor of cyclic guanosine monophosphate-dependent protein kinase Iα, Rp-8-[(4-chlorophenyl)thio]-cGMPS triethylamine, produced a significant antinociception demonstrated by the decrease in the number of flinches and shakes in the formalin test. This was accompanied by a marked reduction in formalin-induced c-fos expression in the spinal dorsal horn. Moreover, cyclic guanosine monophosphate-dependent protein kinase Iα protein expression was dramatically increased in the lumbar spinal cord 96h after injection of formalin into a hindpaw, which occurred mainly in the superficial laminae on the ipsilateral side of a formalin-injected hindpaw. This up-regulation of cyclic guanosine monophosphate-dependent protein kinase Iα expression was completely blocked not only by a neuronal nitric oxide synthase inhibitor, 7-nitroindazole, and a soluble guanylate cyclase inhibitor, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one, but also by an N-methyl-D-aspartate receptor antagonist, dizocilpine maleate (MK-801).The present results indicate that noxious stimulation not only initially activates but also later up-regulates cyclic guanosine monophosphate-dependent protein kinase Iα expression in the superficial laminae via an N-methyl-D-aspartate-nitric oxide-cyclic guanosine monophosphate signaling pathway, suggesting that cyclic guanosine monophosphate-dependent protein kinase Iα may play an important role in the central mechanism of formalin-induced inflammatory hyperalgesia in the spinal cord. Copyright (C) 1999 IBRO.
KW - Hyperalgesia
KW - N-methyl-D-aspartate
KW - Nitric oxide synthase
KW - PKG Iα
KW - Soluble guanylate cyclase
KW - Spinal cord
UR - http://www.scopus.com/inward/record.url?scp=0032714373&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0032714373&partnerID=8YFLogxK
U2 - 10.1016/S0306-4522(99)00438-8
DO - 10.1016/S0306-4522(99)00438-8
M3 - Article
C2 - 10658633
AN - SCOPUS:0032714373
SN - 0306-4522
VL - 95
SP - 525
EP - 533
JO - Neuroscience
JF - Neuroscience
IS - 2
ER -